FAQ

Stage III Colon Cancer

Known as: Stage III Colonic Carcinoma AJCC v6, cancer colon iii stage, colon cancer stage iii 
Stage III includes: IIIA (T1-T2, N1, M0); IIIB (T3-T4, N1, M0); IIIC (Any T, N2, M0). N1: Metastasis in 1 to 3 regional lymph nodes. N2: Metastasis… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-2018
0204019902018

Related topics

Related topics

21 relations
APC geneAbdominal PainBRAF Gene MutationBRAF gene
(More)

Related mentions per year

Related mentions per year

1936-2019
19401960198020002020
Stage III Colon Cancer
cancer cell
Fever
Abdominal Pain
Colon structure (body structure)
Gastrointestinal system

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer.
PURPOSE This multicenter, randomized trial compared capecitabine plus oxaliplatin (XELOX) with bolus fluorouracil (FU) and… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.
PURPOSE Colon cancers exhibiting DNA mismatch repair (MMR) defects demonstrate distinct clinical and pathologic features… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer.
CONTEXT Dietary factors have been associated with the risk of developing colon cancer but the influence of diet on patients with… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.
PURPOSE Randomized studies have shown that irinotecan (CPT-11) extends survival in metastatic colorectal cancer patients when… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
PURPOSE Regular physical activity reduces the risk of developing colon cancer, however, its influence on patients with… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Capecitabine as adjuvant treatment for stage III colon cancer.
BACKGROUND Intravenous bolus fluorouracil plus leucovorin is the standard adjuvant treatment for colon cancer. The oral… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.
BACKGROUND Colon cancers with high-frequency microsatellite instability have clinical and pathological features that distinguish… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Age and adjuvant chemotherapy use after surgery for stage III colon cancer.
BACKGROUND Randomized trials have established that 5-fluorouracil-based adjuvant chemotherapy following resection of stage III… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Molecular predictors of survival after adjuvant chemotherapy for colon cancer.
BACKGROUND Adjuvant chemotherapy improves survival among patients with stage III colon cancer, but no reliable molecular… (More)
  • figure 1
  • table 2
  • table 3
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report.
OBJECTIVE To determine the effectiveness of two adjuvant therapy regimens in improving surgical cure rates in stage III (Dukes… (More)
Is this relevant?